ARTMS Inc. (ARTMS) is excited to announce Health Canada’s marketing approval of cyclotron produced technetium-99m (99mTc) for clinical use. For the He ...

BWXT cautions that this release contains forward-looking statements, including statements relating to the production, performance, timing, impact and value of Tc-99m and changes in demand, benefit ...

BWX Technologies, Inc. announced today that it has successfully labeled technetium-99m derived from its proprietary molybdenum-99 production process and its proprietary Tc-99m generators with nine ...

Technetium-99m (Tc-99m) radiopharmaceuticals are the major diagnostic tools in the clinical practice of nuclear medicine worldwide covering 35 million procedures annually. They play an important role ...

The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical ...

The FDA and the Nuclear Regulatory Agency have cleared the use of NorthStar Medical’s RadioGenix system to produce technetium-99m (Tc-99m), giving the U.S. its own source of the isotope for the ...

Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. A ...

Navidea Biopharmaceuticals Inc. recently announced its clinical trial protocol for a technetium Tc 99m tilmanocept injection was approved by the Institutional Review Board from the University of ...

Due to the widespread availability of 99m Tc generators supplied from fission production of 99 Mo, alternative supply sources such as technetium radioisotope production directly from conventional ...